<?xml version="1.0" encoding="UTF-8"?>
<html><body class="spl" id="spl">
<div class="DocumentTitle"><p class="DocumentTitle"><strong>LACTULOSE- lactulose solution </strong><br>Unit Dose Services<br></p></div>
<h1>LACTULOSE SOLUTION, USP
        <br><br>
</h1>
<div class="Contents">
<div class="Section" data-sectionCode="48780-1">
<a name="section-1"></a><p></p>
</div>
<div class="Section" data-sectionCode="42229-5">
<a name="i4i_section_id_7ab4728c-2aab-4e4c-9120-25ef9280cddc"></a><a name="section-1"></a><p></p>
<p class="First"><span class="Bold">FOR ORAL ADMINISTRATION</span></p>
</div>
<div class="Section" data-sectionCode="34089-3">
<a name="i4i_description_id_b42a7e38-b738-42c2-ac10-a074f4811800"></a><a name="section-2"></a><p></p>
<h1>DESCRIPTION</h1>
<p class="First">Lactulose is a synthetic disaccharide in solution form for oral administration.   Each 15 mL of lactulose solution contains: 10 g lactulose (and less than 1 6 g galactose, less than 1 2 g lactose, and 1.2 g or less of other sugars). Also contains water. The pH range is 4.8 to 6.0.
                            <span class="Bold">.</span><span class="Bold">.</span></p>
<p>Lactulose is a colonic acidifier which promotes laxation.</p>
<p>The chemical name for lactulose is 4-O-β-D-galactopyranosyl-D-fructofuranose. The molecular formula is C H O . t has the following structural formula:
                            <span class="Sub">12</span><span class="Sub">22</span><span class="Sub">11</span></p>
<p><img alt="Lactulose Formula" src="http://dailymed.nlm.nih.gov/dailymed/image.cfm?setid=8a42c3af-b08d-4fd4-b2f7-4eda676921f2&amp;name=c3b21753-316e-4a50-b869-77aa4b6d1d16-01.jpg"></p>
<p>The molecular weight is 342 30. It is freely soluble in water.
                            <span class="Bold">.</span></p>
</div>
<div class="Section" data-sectionCode="34090-1">
<a name="i4i_clinical_pharmacology_id_750d8468-3974-47b2-bc32-1dfaa9036492"></a><a name="section-3"></a><p></p>
<h1>CLINICAL PHARMACOLOGY</h1>
<p class="First">Lactulose is poorly absorbed from the gastrointestinal tract and no enzyme capable of hydrolysis of this disaccharide is present in human gastrointestinal tissue. As a result, oral doses of lactulose reach the colon virtually unchanged. In the colon, lactulose is broken down primarily to lactic acid, and also to small amounts of formic and acetic acids, by the action of colonic bacteria, which results in an increase in osmotic pressure and slight acidification of the colonic contents. This in turn causes an increase in stool water content and softens the stool.</p>
<p>Since lactulose does not exert its effect until it reaches the colon, and since transit time through the colon may be slow, 24 to 48 hours may be required to produce the desired bowel movement.</p>
<p>Lactulose given orally to man and experimental animals resulted in only small amounts reaching the blood. Urinary excretion has been determined to be 3% or less and is essentially complete within 24 hours.</p>
</div>
<div class="Section" data-sectionCode="34067-9">
<a name="i4i_indications_id_d14af4e2-bb16-4086-9f8b-efe8c939df5a"></a><a name="section-4"></a><p></p>
<h1>INDICATIONS AND USAGE</h1>
<p class="First">For the treatment of <span class="product-label-link" type="condition" conceptid="75860" conceptname="Constipation">constipation</span>. In patients with a history of chronic <span class="product-label-link" type="condition" conceptid="75860" conceptname="Constipation">constipation</span>, lactulose solution therapy increases the number of bowel movements per day and the number of days on which bowel movements occur.</p>
</div>
<div class="Section" data-sectionCode="34070-3">
<a name="i4i_contraindications_id_a14ef5ca-b22b-4a77-9e8d-cd22df726c57"></a><a name="section-5"></a><p></p>
<h1>CONTRAINDICATIONS</h1>
<p class="First">Since lactulose solution contains galactose (less than 1 6 g/15 mL), it is contraindicated in patients who require a low galactose diet.
                            <span class="Bold">.</span></p>
</div>
<div class="Section" data-sectionCode="34071-1">
<a name="i4i_warnings_id_030ffc8e-a0c0-4e26-92c3-3d60876ae834"></a><a name="section-6"></a><p></p>
<h1>WARNINGS</h1>
<p class="First">A theoretical hazard may exist for patients being treated with lactulose solution who may be required to undergo electrocautery procedures during proctoscopy or colonoscopy. Accumulation of H gas in significant concentration in the presence of an electrical spark may result in an explosive reaction. Although this complication has not been reported with lactulose, patients on lactulose therapy undergoing such procedures should have a thorough bowel cleansing with a non-fermentable solution. Insufflation of CO as an additional safeguard may be pursued but is considered to be a redundant measure.
                            <span class="Sub">2</span><span class="Sub">2</span></p>
</div>
<div class="Section" data-sectionCode="42232-9">
<a name="i4i_precautions_id_720dd4f0-9b33-482e-b5b9-fd6966c9c66e"></a><a name="section-7"></a><p></p>
<h1>PRECAUTIONS</h1>
<div class="Section" data-sectionCode="34072-9">
<a name="i4i_precautions_general_id_9d802091-db76-416d-8c76-dadd8367cf2f"></a><a name="section-7.1"></a><p></p>
<h2>General</h2>
<p class="First">Since lactulose solution contains galactose (less than 1 6 g/15 mL) and lactose (less than 1 2 g/15 mL) it should be used with caution in diabetics.
                                    <span class="Bold">.</span><span class="Bold">.</span></p>
</div>
<div class="Section" data-sectionCode="42229-5">
<a name="i4i_section_id_2ca09b8e-f5f3-44b4-a805-c645e65c78da"></a><a name="section-7.2"></a><p></p>
<h2>Information for Patients</h2>
<p class="First">In the event that an unusual diarrheal condition occurs, contact your physician.</p>
</div>
<div class="Section" data-sectionCode="42229-5">
<a name="i4i_section_id_73b0a13e-fd8e-48c1-89a2-12385d7ee077"></a><a name="section-7.3"></a><p></p>
<h2>Laboratory Tests</h2>
<p class="First">Elderly, debilitated patients who receive lactulose for more than six months should have serum electrolytes (potassium, chloride, <span class="product-label-link" type="condition" conceptid="4135927" conceptname="Carbon dioxide">carbon dioxide</span>) measured periodically.</p>
</div>
<div class="Section" data-sectionCode="42229-5">
<a name="i4i_section_id_93092e3e-6da6-486e-985a-235dbc18b0b7"></a><a name="section-7.4"></a><p></p>
<h2>Drug Interactions</h2>
<p class="First">Results of preliminary studies in humans and rats suggest that non-absorbable antacids given concurrently with lactulose may inhibit the desired lactulose-induced drop in colonic pH. Therefore, a possible lack of desired effect of treatment should be taken into consideration before such drugs are given concomitantly with lactulose solution.</p>
</div>
<div class="Section" data-sectionCode="42229-5">
<a name="i4i_section_id_f7f2555f-b4cf-423a-bd1e-c4bd5effe81f"></a><a name="section-7.5"></a><p></p>
<h2>Carcinogenesis, Mutagenesis, Impairment of Fertility</h2>
<p class="First">There are no known human data on long-term potential for carcinogenicity, mutagenicity, or impairment of fertility.</p>
<p>There are no known animal data on long-term potential for mutagenicity.</p>
<p>Administration of lactulose solution in the diet of mice for 18 months in concentrations of 3 and 10 percent (v/w) did not produce any evidence of carcinogenicity.</p>
<p>In studies of mice, rats, and rabbits, doses of lactulose solution up to 6 or 12 mL/kg/day produced no deleterious effects in breeding, conception, or parturition.</p>
</div>
<div class="Section" data-sectionCode="42229-5">
<a name="i4i_section_id_d2c76289-a3dd-47ee-bb46-2920c3f8c27b"></a><a name="section-7.6"></a><p></p>
<h2>Pregnancy</h2>
<div class="Section" data-sectionCode="42229-5">
<a name="i4i_section_id_90577a8b-f8cd-4565-a062-24c2508f3a75"></a><a name="section-7.6.1"></a><p></p>
<h3>Teratogenic Effects</h3>
<p class="First">. Reproduction studies have been performed in mice, rats, and rabbits at doses up to 3 or 6 times the usual human oral dose and have revealed no evidence of impaired fertility or harm to the fetus due to lactulose. There are, however, no adequate and well-controlled studies in pregnant women. Because animal reproduction studies are not always predictive of human response, this drug should be used during pregnancy only if clearly needed.
                                            <span class="Italics">Pregnancy category B</span></p>
</div>
</div>
<div class="Section" data-sectionCode="42229-5">
<a name="i4i_section_id_72f7689b-6b1d-4a3d-950d-3b20ab5966d0"></a><a name="section-7.7"></a><p></p>
<h2>Nursing Mothers</h2>
<p class="First">It is not known whether this drug is excreted in human milk. Because many drugs are excreted in human milk, caution should be exercised when lactulose solution is administered to a nursing woman.</p>
</div>
<div class="Section" data-sectionCode="42229-5">
<a name="i4i_section_id_6dcf4103-cdc5-4495-9de9-133f94fb2f7e"></a><a name="section-7.8"></a><p></p>
<h2>Pediatric Use</h2>
<p class="First">Safety and effectiveness in pediatric patients have not been established.</p>
</div>
</div>
<div class="Section" data-sectionCode="34084-4">
<a name="i4i_adverse_effects_id_37e939bb-6b9e-4f25-963a-7acc0d44a434"></a><a name="section-8"></a><p></p>
<h1>ADVERSE REACTIONS</h1>
<p class="First">Precise frequency data are not available.</p>
<p>Initial dosing may produce <span class="product-label-link" type="condition" conceptid="4012503" conceptname="Excessive upper gastrointestinal gas">flatulence</span> and <span class="product-label-link" type="condition" conceptid="4091963" conceptname="Bowel spasm">intestinal cramps</span>, which are usually transient. Excessive dosage can lead to <span class="product-label-link" type="condition" conceptid="80141" conceptname="Functional diarrhea">diarrhea</span> with potential complications such as loss of fluids, <span class="product-label-link" type="condition" conceptid="437833" conceptname="Hypokalemia">hypokalemia</span>, and <span class="product-label-link" type="condition" conceptid="4190305" conceptname="Hypernatremia">hypernatremia</span>.</p>
<p><span class="product-label-link" type="condition" conceptid="31967" conceptname="Nausea">Nausea</span> and <span class="product-label-link" type="condition" conceptid="441408" conceptname="Vomiting">vomiting</span> have been reported.</p>
<p>To report SUSPECTED ADVERSE REACTIONS, contact Hi-Tech Pharmacal Co., Inc. at 1-800-262-9010 or FDA at 1-800-FDA-1088 or www.fda.gov/medwatch.</p>
</div>
<div class="Section" data-sectionCode="34088-5">
<a name="i4i_overdosage_id_b9efeac2-ce98-454e-9d95-424dec3a8f7b"></a><a name="section-9"></a><p></p>
<h1>OVERDOSAGE</h1>
<div class="Section" data-sectionCode="42229-5">
<a name="i4i_section_id_d0965f88-6a01-4177-be65-8ef22d1e89c0"></a><a name="section-9.1"></a><p></p>
<h2>Signs And Symptoms:</h2>
<p class="First">There have been no reports of accidental overdosage. In the event of overdosage, it is expected that <span class="product-label-link" type="condition" conceptid="80141" conceptname="Functional diarrhea">diarrhea</span> and <span class="product-label-link" type="condition" conceptid="200219" conceptname="Abdominal pain">abdominal cramps</span> would be the major symptoms. Medication should be terminated.</p>
<p>The acute oral LD of the drug is 48 8 mL/kg in mice and greater than 30 mL/kg in rats.
                                    <span class="Bold">Oral LD</span><span class="Bold"><span class="Sub">50</span></span><span class="Bold">:</span><span class="Sub">50</span><span class="Bold">.</span></p>
<p>Dialysis data are not available for lactulose. Its molecular similarity to sucrose, however, would suggest that it should be dialyzable.
                                    <span class="Bold">Dialysis:</span></p>
</div>
</div>
<div class="Section" data-sectionCode="34068-7">
<a name="i4i_dosage_admin_id_8843af07-873b-426a-9d5f-b444e99bd1ac"></a><a name="section-10"></a><p></p>
<h1>DOSAGE AND ADMINISTRATION</h1>
<p class="First">The usual dose is 1 to 2 tablespoonfuls (15 to 30 mL, containing 10 g to 20 g of lactulose) daily. The dose may be increased to 60 mL daily if necessary. Twenty-four to 48 hours may be required to produce a normal bowel movement.</p>
<p>Note: Some patients have found that lactulose solution may be more acceptable when mixed with fruit juice, water or milk.</p>
</div>
<div class="Section" data-sectionCode="34069-5">
<a name="i4i_how_supplied_id_7892512f-5863-413e-b436-e731963f8726"></a><a name="section-11"></a><p></p>
<h1>HOW SUPPLIED</h1>
<p class="First">NDC:50436-3101-2 in a BOTTLE of 946 SOLUTIONS</p>
</div>
<div class="Section" data-sectionCode="51945-4">
<a name="i4i_Principal_display_panel_id_e9ac9209-2649-4739-93b0-1b1a3183078d"></a><a name="section-12"></a><p></p>
<h1>LACTULOSE SOLUTION</h1>
<div class="Figure"><img alt="Label Image" src="http://dailymed.nlm.nih.gov/dailymed/image.cfm?setid=8a42c3af-b08d-4fd4-b2f7-4eda676921f2&amp;name=50436-3101.jpg"></div>
</div>
</div>
<div class="DataElementsTables">
<table class="contentTablePetite" cellSpacing="0" cellPadding="3" width="100%"><tbody>
<tr><td class="contentTableTitle">
<strong>LACTULOSE 		
					</strong><br><span class="contentTableReg">lactulose solution</span>
</td></tr>
<tr><td><table width="100%" cellpadding="5" cellspacing="0" class="formTablePetite">
<tr><td colspan="4" class="formHeadingTitle">Product Information</td></tr>
<tr class="formTableRowAlt">
<td class="formLabel">Product Type</td>
<td class="formItem">HUMAN PRESCRIPTION DRUG LABEL</td>
<td class="formLabel">Item Code (Source)</td>
<td class="formItem">NDC:50436-3101(NDC:50383-779)</td>
</tr>
<tr class="formTableRow">
<td width="30%" class="formLabel">Route of Administration</td>
<td class="formItem">ORAL</td>
<td width="30%" class="formLabel">DEA Schedule</td>
<td class="formItem">    
							</td>
</tr>
</table></td></tr>
<tr><td><table width="100%" cellpadding="3" cellspacing="0" class="formTablePetite">
<tr><td colspan="3" class="formHeadingTitle">Active Ingredient/Active Moiety</td></tr>
<tr>
<th class="formTitle" scope="col">Ingredient Name</th>
<th class="formTitle" scope="col">Basis of Strength</th>
<th class="formTitle" scope="col">Strength</th>
</tr>
<tr class="formTableRowAlt">
<td class="formItem">
<strong>LACTULOSE</strong> (LACTULOSE) </td>
<td class="formItem">LACTULOSE</td>
<td class="formItem">10 g  in 15 mL</td>
</tr>
</table></td></tr>
<tr><td><table width="100%" cellpadding="3" cellspacing="0" class="formTablePetite">
<tr><td colspan="2" class="formHeadingTitle">Inactive Ingredients</td></tr>
<tr>
<th class="formTitle" scope="col">Ingredient Name</th>
<th class="formTitle" scope="col">Strength</th>
</tr>
<tr class="formTableRowAlt">
<td class="formItem"><strong>GALACTOSE</strong></td>
<td class="formItem"> </td>
</tr>
<tr class="formTableRow">
<td class="formItem"><strong>LACTOSE</strong></td>
<td class="formItem"> </td>
</tr>
<tr class="formTableRowAlt">
<td class="formItem"><strong>WATER</strong></td>
<td class="formItem"> </td>
</tr>
<tr class="formTableRow">
<td class="formItem"><strong>SODIUM HYDROXIDE</strong></td>
<td class="formItem"> </td>
</tr>
</table></td></tr>
<tr><td></td></tr>
<tr><td><table width="100%" cellpadding="3" cellspacing="0" class="formTablePetite">
<tr><td colspan="5" class="formHeadingTitle">Packaging</td></tr>
<tr>
<th scope="col" width="1" class="formTitle">#</th>
<th scope="col" class="formTitle">Item Code</th>
<th scope="col" class="formTitle">Package Description</th>
<th scope="col" class="formTitle">Marketing Start Date</th>
<th scope="col" class="formTitle">Marketing End Date</th>
</tr>
<tr class="formTableRowAlt">
<th scope="row" class="formItem">1</th>
<td class="formItem">NDC:50436-3101-2</td>
<td class="formItem">946 mL in 1 BOTTLE</td>
<td class="formItem"></td>
<td class="formItem"></td>
</tr>
</table></td></tr>
<tr><td></td></tr>
<tr><td class="normalizer"><table width="100%" cellpadding="3" cellspacing="0" class="formTableMorePetite">
<tr><td colspan="4" class="formHeadingReg"><span class="formHeadingTitle">Marketing Information</span></td></tr>
<tr>
<th scope="col" class="formTitle">Marketing Category</th>
<th scope="col" class="formTitle">Application Number or Monograph Citation</th>
<th scope="col" class="formTitle">Marketing Start Date</th>
<th scope="col" class="formTitle">Marketing End Date</th>
</tr>
<tr class="formTableRowAlt">
<td class="formItem">ANDA</td>
<td class="formItem">ANDA074076</td>
<td class="formItem">07/03/1995</td>
<td class="formItem"></td>
</tr>
</table></td></tr>
</tbody></table>
<table width="100%" cellpadding="3" cellspacing="0" class="formTableMorePetite"><tr><td colspan="4" class="formHeadingReg">
<span class="formHeadingTitle">Labeler - </span>Unit Dose Services
							(831995316)
						</td></tr></table>
<table width="100%" cellpadding="3" cellspacing="0" class="formTableMorePetite"><tr><td colspan="4" class="formHeadingReg">
<span class="formHeadingTitle">Registrant - </span>Unit Dose Services (831995316)</td></tr></table>
<table width="100%" cellpadding="3" cellspacing="0" class="formTableMorePetite">
<tr><td colspan="4" class="formHeadingReg"><span class="formHeadingTitle">Establishment</span></td></tr>
<tr>
<th scope="col" class="formTitle">Name</th>
<th scope="col" class="formTitle">Address</th>
<th scope="col" class="formTitle">ID/FEI</th>
<th scope="col" class="formTitle">Business Operations</th>
</tr>
<tr class="formTableRowAlt">
<td class="formItem">Unit Dose Services</td>
<td class="formItem"></td>
<td class="formItem">831995316</td>
<td class="formItem">REPACK(50436-3101)</td>
</tr>
</table>
</div>
<p><div class="EffectiveDate">Revised: 3/2013<div class="DocumentMetadata">
<div>
<a href="javascript:toggleMixin();">Document Id: </a>1fbb4409-8ca5-481d-9261-57c5e9fe06b4</div>
<div>Set id: 8a42c3af-b08d-4fd4-b2f7-4eda676921f2</div>
<div>Version: 3</div>
<div>Effective Time: 20130323</div>
</div>
</div> <div class="DistributorName">Unit Dose Services</div></p>
</body></html>
